Search Results

Penumbra’s CAVT With Anticoagulation Studied in STORM-PE

October 27, 2025—Penumbra, Inc. announced that the results of the STORM-PE randomized controlled trial showed that mechanical thrombectomy using the company’s computer assisted vacuum thrombectomy (CAVT) system with anticoagulation achieved superior reduction in right heart strain compared to anticoagulation therapy alone in patients with acute intermediate–high-risk pulmonary embolism (PE).

Primary Results From STORM-PE RCT Presented for Penumbra’s CAVT System

November 3, 2025—Penumbra, Inc. announced that results of the STORM-PE randomized controlled trial (RCT) were presented at VIVA 2025, the Vascular Interventional Advances conference.

Penumbra’s STORM-PE Pivotal Trial of Lightning Flash CAVT Completes Enrollment

June 16, 2025—Penumbra, Inc. announced the completion of enrollment in the pivotal STORM-PE prospective, multicenter, randomized controlled trial.

Penumbra’s CAVT Evaluated in 90-Day STORM-PE Data

April 13, 2026—Penumbra, Inc. announced 90-day results of the STORM-PE randomized controlled trial (RCT) that is evaluating computer-assisted vacuum thrombectomy (CAVT) using Penumbra’s Lightning Flash device plus anticoagulation versus anticoagulation alone for the treatment of patients with acute intermediate-high risk pulmonary embolism (PE).

Penumbra Enrolls First Patient in STORM-PE Trial for Lightning Flash Thrombectomy in Acute PE

November 28, 2023—Penumbra, Inc. announced that the first patient was enrolled in the prospective, multicenter STORM-PE randomized controlled trial (RCT), which is evaluating anticoagulation alone versus anticoagulation plus Penumbra’s Lightning Flash for the treatment of pulmonary embolism (PE).

Get Out the Clot Campaign Launched to Address VTE Care

October 10, 2024—The launch of the Get Out the Clot campaign (GetOutTheClot.com) was announced in advance of World Thrombosis Day (WorldThrombosisDay.org)—which is held on October 13—by Penumbra, Inc., The International Society on Thrombosis and Hemostasis (ISTH), National Blood Clot Alliance (NBCA; www.StopTheClot.org), The Pulmonary Embolism Response Team (PERT) Consortium, and the Society for Vascular Medicine (SVM).